Your browser doesn't support javascript.
loading
No indication of increased infection rates using low-dose alemtuzumab instead of anti-thymocyte globulin as graft-versus-host disease prophylaxis before allogeneic stem cell transplantation.
Neumann, Thomas; Schneidewind, Laila; Thiele, Thomas; Pink, Daniel; Schulze, Meike; Schmidt, Christian; Krüger, William.
Afiliación
  • Neumann T; Department of Haematology, Oncology, Transplantation, University Medical Centre, Ernst-Moritz-Arndt University, Greifswald, Germany.
  • Schneidewind L; Department of Haematology, Oncology, Transplantation, University Medical Centre, Ernst-Moritz-Arndt University, Greifswald, Germany.
  • Thiele T; Institute of Immunology and Transfusion Medicine, University Medical Centre, Ernst-Moritz-Arndt University, Greifswald, Germany.
  • Pink D; Department of Haematology, Oncology, HELIOS Klinikum Bad Saarow, Bad Saarow, Germany.
  • Schulze M; Department of Internal Medicine, Wolgast Hospital, Wolgast, Germany.
  • Schmidt C; Department of Haematology, Oncology, Transplantation, University Medical Centre, Ernst-Moritz-Arndt University, Greifswald, Germany.
  • Krüger W; Department of Haematology, Oncology, Transplantation, University Medical Centre, Ernst-Moritz-Arndt University, Greifswald, Germany.
Transpl Infect Dis ; 20(1)2018 Feb.
Article en En | MEDLINE | ID: mdl-29178248
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Alemtuzumab / Enfermedad Injerto contra Huésped / Infecciones / Suero Antilinfocítico Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Alemtuzumab / Enfermedad Injerto contra Huésped / Infecciones / Suero Antilinfocítico Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Alemania